OTCMKTS:MDCN

Medican Enterprises Competitors

$0.0008

0.00 (-11.11 %)

(As of 04/16/2021 08:09 PM ET)

Add

Compare

Today's Range

$0.00

Now: $0.00▼

$0.00

50-Day Range N/A

52-Week Range

$0.00

Now: $0.00▼

$0.00

Volume451.17 million shs

Average Volume720.23 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Medican Enterprises (OTCMKTS:MDCN) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying MDCN stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to Medican Enterprises, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Medican Enterprises vs. Innovative Industrial Properties Stock

Innovative Industrial Properties (NYSE:IIPR) and Medican Enterprises (OTCMKTS:MDCN) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and target prices for Innovative Industrial Properties and Medican Enterprises, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Industrial Properties	0	2	5	0	2.71
Medican Enterprises	0	0	0	0	N/A

Innovative Industrial Properties currently has a consensus target price of $192.4286, suggesting a potential upside of 4.05%. Given Innovative Industrial Properties' higher probable upside, analysts clearly believe Innovative Industrial Properties is more favorable than Medican Enterprises.

Profitability

This table compares Innovative Industrial Properties and Medican Enterprises' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Innovative Industrial Properties	55.71%	6.05%	4.82%
Medican Enterprises	N/A	N/A	N/A

Valuation & Earnings

This table compares Innovative Industrial Properties and Medican Enterprises' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Industrial Properties	$44.67 million	99.06	$23.48 million	$3.27	56.56
Medican Enterprises	N/A	N/A	N/A	N/A	N/A

Innovative Industrial Properties has higher revenue and earnings than Medican Enterprises.

Summary

Innovative Industrial Properties beats Medican Enterprises on 8 of the 8 factors compared between the two stocks.

Medican Enterprises vs. GrowGeneration Stock

GrowGeneration (NASDAQ:GRWG) and Medican Enterprises (OTCMKTS:MDCN) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Valuation & Earnings

This table compares GrowGeneration and Medican Enterprises' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GrowGeneration	$79 million	34.85	$1.88 million	$0.10	471.00
Medican Enterprises	N/A	N/A	N/A	N/A	N/A

GrowGeneration has higher revenue and earnings than Medican Enterprises.

Analyst Ratings

This is a summary of current ratings and target prices for GrowGeneration and Medican Enterprises, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GrowGeneration	0	3	5	0	2.63
Medican Enterprises	0	0	0	0	N/A

GrowGeneration currently has a consensus target price of $49.5714, suggesting a potential upside of 5.25%. Given GrowGeneration's higher probable upside, analysts clearly believe GrowGeneration is more favorable than Medican Enterprises.

Profitability

This table compares GrowGeneration and Medican Enterprises' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GrowGeneration	2.14%	4.68%	3.53%
Medican Enterprises	N/A	N/A	N/A

Institutional & Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

GrowGeneration beats Medican Enterprises on 8 of the 8 factors compared between the two stocks.

Medican Enterprises vs. 22nd Century Group Stock

Medican Enterprises (OTCMKTS:MDCN) and 22nd Century Group (NYSEAMERICAN:XXII) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and 22nd Century Group's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medican Enterprises	N/A	N/A	N/A	N/A	N/A
22nd Century Group	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and 22nd Century Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medican Enterprises	0	0	0	0	N/A
22nd Century Group	0	0	1	0	3.00

Profitability

This table compares Medican Enterprises and 22nd Century Group's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medican Enterprises	N/A	N/A	N/A
22nd Century Group	N/A	N/A	N/A

Summary

22nd Century Group beats Medican Enterprises on 1 of the 1 factors compared between the two stocks.

Medican Enterprises vs. KushCo Stock

Medican Enterprises (OTCMKTS:MDCN) and KushCo (OTCMKTS:KSHB) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and KushCo's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medican Enterprises	N/A	N/A	N/A	N/A	N/A
KushCo	$113.84 million	1.65	$-77,660,000.00	($0.68)	-1.74

Medican Enterprises has higher earnings, but lower revenue than KushCo.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and KushCo, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medican Enterprises	0	0	0	0	N/A
KushCo	0	1	3	0	2.75

KushCo has a consensus target price of $1.8750, suggesting a potential upside of 58.90%. Given KushCo's higher probable upside, analysts plainly believe KushCo is more favorable than Medican Enterprises.

Profitability

This table compares Medican Enterprises and KushCo's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medican Enterprises	N/A	N/A	N/A
KushCo	-65.89%	-47.95%	-31.39%

Insider and Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

KushCo beats Medican Enterprises on 5 of the 8 factors compared between the two stocks.

Medican Enterprises vs. NSAV Stock

Medican Enterprises (OTCMKTS:MDCN) and NSAV (OTCMKTS:NSAV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and NSAV's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medican Enterprises	N/A	N/A	N/A	N/A	N/A
NSAV	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and NSAV, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medican Enterprises	0	0	0	0	N/A
NSAV	0	0	0	0	N/A

Profitability

This table compares Medican Enterprises and NSAV's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medican Enterprises	N/A	N/A	N/A
NSAV	N/A	N/A	N/A

Medican Enterprises vs. Terra Tech Stock

Medican Enterprises (OTCMKTS:MDCN) and Terra Tech (OTCMKTS:TRTC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and Terra Tech's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medican Enterprises	N/A	N/A	N/A	N/A	N/A
Terra Tech	$28.05 million	2.15	$-46,930,000.00	N/A	N/A

Medican Enterprises has higher earnings, but lower revenue than Terra Tech.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and Terra Tech, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medican Enterprises	0	0	0	0	N/A
Terra Tech	0	0	0	0	N/A

Profitability

This table compares Medican Enterprises and Terra Tech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medican Enterprises	N/A	N/A	N/A
Terra Tech	-261.88%	-110.38%	-62.41%

Insider and Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.